Olivier Saulnier

16PUBLICATIONS
136CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 20, 2026
Medulloblastoma Forms Symbiotic Metabolic Partnerships with Macrophages to Establish Leptomeningeal Metastases.

|Jul 25, 2025
Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy.

Cory M Richman, Alexandra Rasnitsyn, Borja L Holgado

|Jul 18, 2024
A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing.

Olivier Saulnier, Jamie Zagozewski, Lisa Liang

|Jan 03, 2024
Lymphatic endothelial-like cells promote glioblastoma stem cell growth through cytokine-driven cholesterol metabolism.

Linjie Zhao, Zhixin Qiu, Zhengnan Yang

|Jun 21, 2023
The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survival.

Shubin W Shahab, Christianna M Roggeveen, Jiarong Sun

|Feb 27, 2023
A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasis.

Han Zou, Bradley Poore, Emily E Brown

Pageof 3

Frequent Collaborators

9 joint publications

Michael D Taylor

6 joint publications

Tamra E Werbowetski-Ogilvie

5 joint publications

Vijay Ramaswamy

4 joint publications

Christopher J Porter